Publications
2008-2009 Publications
Hyon Choi
Choi HK, Gao X, Curhan G. Vitamin C Intake and the Risk of Gout in Men – A Prospective Study. Arch Intern Med 2009; 169(5):502-507.
Gene Kissin
Lafyatis R, Kissin E, York M, Farina G, Viger K, Fritzler MJ, Merkel P, SIMMS. B cell depletion in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 60(2): 578-584.
Bob Lafyatis
Farina G, Lemaire R, Pancari P, Bayle J, Widom RL, Lafyatis R. Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor beta. Ann Rheum Dis 2009;68(3):435-41.
Lafyatis R, Kissin E, York M, Farina G, Viger K, Fritzler MJ, et al. B cell depletion with rituximab in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 2009;60(2):578-83.
Radstake TR, van Bon L, Broen J, Hussiani A, Hesselstrand R, Wuttge DM, et al. The pronounced Th17 profile in systemic sclerosis (SSc) together with intracellular expression of TGFbeta and IFNgamma distinguishes SSc phenotypes. PLoS One 2009;4(6):e5903.
Radstake TR, van Bon L, Broen J, Wenink M, Santegoets K, Deng Y, et al. Increased frequency and compromised function of T regulatory cells in systemic sclerosis (SSc) is related to a diminished CD69 and TGFbeta expression. PLoS One 2009;4(6):e5981.
Radstake TR, Vonk MC, Dekkers M, Schijvenaars MM, Treppichio WL, Lafyatis R, et al. The -2518A>G promoter polymorphism in the CCL2 gene is not associated with systemic sclerosis susceptibility or phenotype: results from a multicenter study of European Caucasian patients. Hum Immunol 2009;70(2):130-3.
Richez C, Yasuda K, Watkins AA, Akira S, Lafyatis R, van Seventer JM, et al. TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta priming. J Immunol 2009;182(2):820-8.
van Lieshout AW, Vonk MC, Bredie SJ, Joosten LB, Netea MG, van Riel PL, et al. Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion. Scand J Rheumatol 2009:1-9.
Peter Merkel
Merkel PA, McCarty DM, Sharma A, Stone JR. Case records of the Massachusetts General Hospital. A 39-Year-Old Man with Chest Pain, Arthralgias, and a Mediastinal Mass. New England Journal of Medicine. 2008; 359:1603-14.
Merkel PA, David Cuthbertson, Hellmich B, Hoffman GS, Jayne DJ, Kallenberg CGM, Krischer J, Luqmani R, Mahr AD, Matteson EL, Specks U, Stone JH, Vasculitis Clinical Research Consortium. Comparison of Disease Activity Measures for ANCA-Associated Vasculitis. Annals of Rheumatic Diseases 2009; 68:103-6; Epub 2008 July 29.
Khanna D, Clements P, Mayes M, Merkel P, Mellman , SIMMS RW, Sanders M, Rothfield N, Steen V, Moreland L, Kavanaugh A, Weisman M, Firestein G, Collier D, Silver R, Wigley F, Csuka ME, Medsger T, Seibold J, Maranian P. A randomized, double-blind placebo-controlled trial of recombinant human relaxin in the treatment of systemic sclerosis with diffuse scleroderma. Arthritis Rheum 60(4): 1102-1111.
Lafyatis R, Kissin E, York M, Farina G, Viger K, Fritzler MJ, Merkel P, SIMMS. B cell depletion in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 60(2): 578-584.
Tuhina Neogi
Neogi T, Felson D, Niu J, Nevitt M, Lewis CE, Aliabadi P, Sack B, Torner J, Bradley L, Zhang Y. The association of radiographic features of knee osteoarthritis and pain: results from two cohorts. BMJ: British Medical Journal. In press. 2009.
Rob Simms
Chung L, Shapiro L, Fiorentino D, Baron M, Shanahan J, Sule S, Hsu V, Rothfield N,
Steen V, Martin R, Smith E, Mayes M, SIMMS RW, Pope J, Kahaleh B, Csuka ME, Gruber B, Collier D, Sweiss N, Gilbert A, Dechow FJ, Gregory J, Wigley FM. MQX-503, A novel formulation of nitroglycerin improves severity of raynaud’s phenomenon: A Randomized controlled trial. Arthritis Rheum 60 (3): 870-877, 2009.
Khanna D, Clements P, Mayes M, Merkel P, Mellman , SIMMS RW, Sanders M, Rothfield N, Steen V, Moreland L, Kavanaugh A, Weisman M, Firestein G, Collier D, Silver R, Wigley F, Csuka ME, Medsger T, Seibold J, Maranian P. A randomized, double-blind placebo-controlled trial of recombinant human relaxin in the treatment of systemic sclerosis with diffuse scleroderma. Arthritis Rheum 60(4): 1102-1111.
Lafyatis R, Kissin E, York M, Farina G, Viger K, Fritzler MJ, Merkel P, SIMMS. B cell depletion in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 60(2): 578-584.
Steve Vlad
Aletaha D, Landewe R, Karonitsch T, Bathon J, Boers M, Bombardier C, Bombardieri S, Choi H, Combe B, Dougados M, Emery P, Gomez-Reino J, Keystone E, Koch G, Kvien TK, Martin-Mola E, Matucci-Cerinic M, Michaud K, O’Dell J, Paulus J, Pincus T, Richards P, Simon L, Siegel J, Smolen JS, Sokka T, Strand V, Tugwell P, van der Heijde D, van Riel P, Vlad S, van Vollenhoven R, Ward M, Weinblatt M, Wells G, White B, Wolfe F, Zhang B, Zink A, Felson D. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations. Annals of the Rheumatic Diseases 2008;67:1360-1364.
van Tuyl LHD*, Vlad SC*, Felson DT, Wells G, Boers M. Defining remission in rheumatoid arthritis: results of an initial American College of Rheumatology/European League Against Rheumatism consensus conference. Arthritis Care & Research 2009;61(5):704-710. (*Co-principal authors)
Vlad SC, Felson DT, Miller DR. Can healthcare databases be used to identify
incident cases of osteonecrosis? Arthritis Research & Therapy 2009;11:R89.
Mike York
Lafyatis R, Kissin E, York M, Farina G, Viger K, Fritzler MJ, Merkel P, SIMMS. B cell depletion in patients with diffuse cutaneous systemic sclerosis. Arthritis Rheum 60(2): 578-584.
Previous Publications
Akar H, Seldin DC, Magnani B, O’Hara C, Berk JL, Schoonmaker C, Cabral H, Dember LM, Sanchorawala V, Connors LH, Falk RH, Skinner M: Quantitative serum free light-chain assay in the diagnostic evaluation of AL amyloidosis. Amyloid: J Protein Folding Disorders, 12: 210-215, 2005.
Aliprantis A., J. Wang, J. Fathman, R. Lemaire, D. Dorfman, R. Lafyatis and L. Glimcher. Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proceedings of National Academy of Sciences of the United States of America. 2007, in press.
Amin S. LaValley MP. Guermazi A. Grigoryan M. Hunter DJ. Clancy M. Niu J. Gale DR. Felson DT. The relationship between cartilage loss on magnetic resonance imaging and radiographic progression in men and women with knee osteoarthritis. Arthritis & Rheumatism. 52(10):3152-9, 2005 Oct.
Bauer DC, Hunter DJ, Abramson SB, Attur M, Corr M, Felson D, Heinegard D, Jordan JM, Kepler TB, Lane NE, Saxne T, Tyree B, Kraus VB, For The Osteoarthritis Biomarkers Network V Kraus Chair. Classification of osteoarthritis biomarkers: a proposed approach. Osteoarthritis Cartilage. 2006 May 27.
Berk JL, Grillone GA, Skinner M, Hartford AC: External beam radiation for tracheobronchial amyloidosis: The Boston University experience. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 463-465, 2005.
Berk JL, Wiesman JF, Skinner M, Sanchorawala V: Diaphragm paralysis in primary systemic amyloidosis. Amyloid: J Protein Folding Disorders, 12: 193-196, 2005.
Bhatia J, Sanchorawala V, Seldin DC, Casserly LF, Berk JL, Falk RH, Skinner M, Dember LM: AL amyloidosis-associated hypothyroidism: prevalence and relationships to nephrotic syndrome. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 93-95, 2005.
Brenner DA, Jain M, Wang B, Pimental DR, Connors LH, Skinner M, Apstein CS, Liao R: Human amyloidogenic light chains directly invoke oxidant stress and result in impaired cardiomyocyte function. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 145-147, 2005.
Chung CM, Chiu JD, Connors LH, Gursky O, Lim A, Dykstra AB, Liepnieks J, Benson MD, Costello CE, Skinner M, Walsh MT: Thermodynamic stability of a I immunoglobulin light chain: relevance to multiple myeloma. Biophys J, 88: 4232-4242, 2005.
Conaghan PG, Tennant A, Peterfy CG, Woodworth T, Stevens R, Guermazi A, Genant H, Felson DT, Hunter D. Examining a whole-organ magnetic resonance imaging scoring system for osteoarthritis of the knee using Rasch analysis. Osteoarthritis Cartilage. 2006;14 Suppl 1:116-21.
Connors LH, Prokaeva T, Akar H, Metayer M, Smith P, Lim A, Costello CE, Skinner M: Familial amyloidosis: recent novel and rare mutations in a clinical population. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp360-362, 2005.
Farina G., R. Lemaire, J.H. Korn, R.L. Widom. Cartilage oligometric matrix protein is overexpressed by scleroderma dermal fibroblast. Matrix Biology 2006, 25, 213-222.
Felson DT. Gale DR. Elon Gale M. Niu J. Hunter DJ. Goggins J. Lavalley MP. Osteophytes and progression of knee osteoarthritis. Rheumatology. 44(1):100-4, 2005 Jan.
Felson DT, Neogi T. Osteoarthritis: Is it a disease of cartilage or bone? Arthritis & Rheumatism. 2004; 50(2):341-344.
Gravallese E, Monach PA. The rheumatoid joint: synovitis and joint destruction. In: Rheumatology, 4th ed. MC Hochberg et al, eds. Elsevier, 2008
Hauck W, Dember LM, Hawkins PN, Hazenberg BPC, Skinner M, Bouwmeester MC, Briand R, Chicoine E, Gurbindo C, Hughes L, Garceau D: A prospective analysis of demography, etiology, and clinical findings of AA amyloidosis patients enrolled in the international clinical phase II/III Fibrillex study. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 179-181, 2005.
Hernandez-Molina G, Neogi T, Hunter DJ, Niu J, Guermazi A, Roemer FW, McLennan CE, Reichenbach SR, Felson DT. The association of bone attrition with knee pain and other features of osteoarthritis. Annals of the Rheumatic Diseases. 2008;67:43-47.
Hunter DJ, et al. Knee height, knee pain and knee osteoarthritis. The Beijing Osteoarthritis Study. Arthritis and Rheumatism. 52(5):1418-23, 2005 May.
Hunter DJ, et al. Structural factors associated with malalignment in knee osteoarthritis: The Boston Osteoarthritis Knee Study. J Rheum 2005 Nov;32(11):2192-9.
Hunter DJ, et al. Trapeziometacarpal subluxation predisposes to incident trapeziometacarpal Osteoarthritis (OA): The Framingham Study. Osteoarthritis and Cartilage 2005, 13; 953-57.
Hunter DJ, Conaghan PG. Imaging outcomes and their role in determining outcomes in OA and RA. (Review) Current Opinion in Rheumatology. 2006; 18: 157-162.
Hunter DJ, Felson DT. Osteoarthritis. (Review) BMJ.2006; 332: 639-642.
Hunter DJ, et al. The Association of Meniscal Pathologic Changes With Cartilage Loss in Symptomatic Knee Osteoarthritis. Arthritis & Rheumatism. 54(3): 795-801, 2006 March.
Hunter DJ, Conaghan PG, Peterfy CG, Bloch D, Guermazi A, Woodworth T, Stevens R, Genant HK. Responsiveness, effect size, and smallest detectable difference of Magnetic Resonance Imaging in knee osteoarthritis. Osteoarthritis Cartilage. 2006;14 Suppl 1:112-5.
Hunter DJ, Zhang Y, Niu J, Goggins J, Amin S, Lavalley MP, Guermazi A, Genant H, Gale D, Felson DT. Increase in bone marrow lesions associated with cartilage loss: A longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum. 2006 May;54(5):1529-35
Hunter DJ, Pollo FE. Biomechanics and Knee Osteoarthritis. (Review) Current Rheumatology Reviews. 2006 May; 2 (2): 123-129.
Hunter DJ, York M, Chaisson CE, Woods R, Niu J, Zhang Y. Recent diuretic use and the risk of recurrent gout attacks: the online case-crossover gout study. J Rheumatol. 2006 Jul;33(7):1341-5.
Johnson SR*, Goek ON*, Singh-Grewal D*, Vlad SC*, Feldman BM, Felson DT, Hawker GA, Singh JA, Solomon DH. Classification Criteria in Rheumatic Diseases: A Systematic Review. Arthritis Care & Research 2007;57(7):1119-1133. (*co-principal authors)
Goek ON*, Singh-Grewal D*, Vlad SC*, Feldman BM, Felson DT, Hawker GA, Singh JA, Solomon DH. Classification Criteria in Rheumatic Diseases: A Systematic Review. Arthritis Care & Research 2007;57(7):1119-1133. (*co-principal authors)
Kissin EY, Merkel PA, Lafyatis R. Myofibroblasts and Hyalinized Collagen as Markers of Skin Disease in Systemic Sclerosis. Arthritis & Rheumatism. 2006; 54 (11): 3655-3660.
Kissin EY, Schiller AM, Gelbard RB, Anderson JJ, Falanga V, Simms RW, Korn JH, Merkel PA. Durometry for the Assessment of Skin Disease in Systemic Sclerosis. Arthritis Care and Research 2006 Aug; 55 (4):603-609.
Kissin EY, Freitas CF, Kissin I. The effects of intraarticular resiniferatoxin in experimental knee-joint arthritis. Anesthesia & Analgesia. 2005 Nov;101(5):1433-9
Lafyatis, R. and J.H. Korn. 2005. Fibroblast Biology, in: Textbook of Rheumatology. E.D. Harris,R.C. Budd, G.S. Firestein, M.C. Genovese, J.S. Sargent, S. Ruddy and C.B. Sledge, Eds. W.B. Saunders.189-202.
Lafyatis R, Kissin E, Viger K, Merkel PA, Simms RW. Rituximab treatment for patients with diffuse cutaneous sclerosis – A phase I study. Arthritis Rheum 54: S523, 2006
Lafyatis R, York, M and Marshak-Rothstein, A. 2006. Antimalarials – Closing the gate on toll-like receptors? Arthritis & Rheum 54: 3068-70
Lafyatis, R. 2006 Targeting fibrosis in Systemic Sclerosis. Endocrine, Metabolic and Immune Disorders in press.
Lemaire R, J. H. Korn, J. M. Shipley, and R. Lafyatis. 2005. MAGP-2 increases type I collagen: novel mechanistic insights into the molecular basis for dermal fibrosis in scleroderma. Arthritis Rheum 52:1812-1823.
Lemaire R, G. Farina, E. Kissin, J.M. Shipley, C. Bona, J.H. Korn, R. Lafyatis. Mutant fibrillin-1 from Tsk mice increases extracellular matrix incorporation of MAGP-2 and type I collagen. Arthritis and Rheumatism 2004. 50:915-926
Lemaire R, J. H. Korn, W. P. Schiemann, R. Lafyatis. Fibulin-2 and Fibulin-5 alterations in Tsk mice associated with disorganized hypodermal elastic fibers and skin tethering. Journal of Investigative Dermatology 2004. 123:1063-1069
Lemaire R, J.H. Korn, J.M. Shipley, R. Lafyatis. MAGP-2 increases type I collagen: novel mechanistic insights into the molecular basis for dermal fibrosis in scleroderma. Arthritis and Rheumatism 2005. 52:1812-1823.
Lemaire R, J. Bayle and R. Lafyatis. Fibrillin in Marfan syndrome and tight skin mice provides new insights into transforming growth factor-beta regulation in systemic sclerosis. Curr Opin Rheumatol 2006, 18(6):582-587.
Lemaire R, J. Bayle, R. Mecham and R. Lafyatis. Microfibril-associated MAGP-2 stimulates elastic fiber assembly. Journal of Biological Chemistry, 2007, in press.
Livshits G, Kato BS, Zhai G, Hart DJ, Hunter D, et al. Genomewide Linkage Scan of Hand Osteoarthritis in Female Twin Pairs Showing Replication of QTLs on Chromosome 2 and 19. Ann Rheum Dis. 2006 Nov 24.
Lo GH, Hunter DJ. et al. Bone marrow lesions in the knee are associated with increased local bone density. Arthritis & Rheumatism. 52(9):2814-21, 2005 Sep.
Lo GH, Zhang Y, McLennan C, Niu J, Kiel DP, McLean RR, Aliabadi P, Felson DT, Hunter DJ. The ratio of medial to lateral tibial plateau bone mineral density and compartment-specific tibiofemoral osteoarthritis. Osteoarthritis and Cartilage. 2006; 14: 984-990.
Mahr A, Neogi T, LaValley M, Davis JC, Hoffman GS, McCune WJ, Specks U, Spiera RF, St. Clair EW, Stone JH, Merkal PA. Wegener’s Granulomatosis Etanercept Trial Research Group. Assessment of the item selection and weighting in the Birmingham Vasculitis Activity Score for Wegener’s Granulomatosis. Arthritis Care & Research. 2008;59(6):884-891
Mahr AD, Neogi T, Merkel PA. Epidemiology of Wegener’s Granulomatosis: Lessons from Descriptive Studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol. 2006;Suppl 41:S82-S91.
McComb ME, Lim A, Theberge R, Prokaeva T, Connors LH, Skinner M, Costello CE: Clinical diagnosis of familial transthyretin amyloidosis by automated data acquisition and processing with quadrupole orthogonal time-of-flight mass spectrometry. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 348-350, 2005.
Merkel PA, Seo P, Aries P, Neogi T, et al. Current status of outcome measures in vasculitis: Focus on Wegener’s granulomatosis and microscopic polyangiitis. Report from OMERACT 7. Journal of Rheumatology. 2005; 32(12):2488-2495.
Monach PA, Verschoor A, Jacobs JP, Carroll MC, Wagers AJ, Benoist C, Mathis D. Circulating C3 is necessary and sufficient for autoantibody-mediated arthritis. Arthritis Rheum 2007;56:2968-74.
Monach P, Hattori K, Huang H, Hyatt E, Morse J, Nguyen L, Ortiz-Lopez A, Wu H-J, Mathis D, Benoist C. The K/BxN mouse model of inflammatory arthritis. In: Arthritis Research: Methods and Protocols, Vol. 2. AP Cope, ed. Humana, 2007. p. 269-282.
Neogi T, Hunter DJ, et al. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol. 2006 Jan;33(1):104-9.
Neogi T, M. Nevitt, J. Niu, M. P. LaValley, D. J. Hunter, et al. Lack of association between chondrocalcinosis and increased risk of cartilage loss in knees with osteoarthritis: Results of two prospective longitudinal magnetic resonance imaging studies. Arthritis Rheum. 2006 May;54(6):1822-28.
Neogi T, Nevitt M, Niu J, LaValley MP, Hunter DJ, Terkeltaub R, Carbone L, Chen H, Harris T, Kwoh K, Guermazi A, Felson DT. Chondrocalcinosis is not associated with increased risk of cartilage loss in knees with osteoarthritis: Results from two prospective longitudinal MRI studies. Arthritis & Rheumatism. 2006;54(6):1822-1828.
Neogi T, Booth SL, Zhang YQ, Jacques PF, Terkeltaub R, Aliabadi P, Felson DT. Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis & Rheumatism. 2006; 54(4):1255-1261.
Neogi T, Allison JJ. Suboptimal osteoporosis management: Moving beyond detection. Journal of Rheumatology. 2004; 31(3):413-415.
Neogi T, Gladman D, Ibanez D, Urowitz M. Anti-dsDNA antibody testing by Farr and ELISA techniques are not equivalent. Journal of Rheumatology. 2006;33(9):1785-9. First release online www.jrheum.com Aug 15 2006.
Neogi T, Zhang YQ. Re: “Easy SAS calculations for risk or prevalence ratios and differences”. American Journal of Epidemiology. 2006;163(12):1157.
Neogi T, Felson DT, Sarno R, Booth SL. Vitamin K in Hand Osteoarthritis: Results from a Randomized Clinical Trial. Annals of the Rheumatic Diseases. Published Online First: 14 July 2008. doi:10.1136/ard.2008.094771
Neogi T. Asymptomatic Hyperuricemia: Perhaps not so benign? Journal of Rheumatology (invited editorial). 2008;35(5):734-737.
Neogi T, Xie H, Felson D. The relative responsiveness of physician/assessor-derived and patient-derived core set measures in rheumatoid arthritis trials. Journal of Rheumatology. 2008;35(5):757-762.
Neogi T, Nevitt MC, Ensrud KE, Bauer D, Felson DT. The effect of alendronate on progression of spinal osteophytes and disc space narrowing. Annals of the Rheumatic Diseases. Published Online First: 14 February 2008. doi:10.1136/ard.2007.085563
Neogi T, Felson D. Composite Versus Individual Measures of Disease Activity in Rheumatoid Arthritis. Journal of Rheumatology. 2008;35(2):185-187.
Ng B, Connors LH, Davidoff R, Skinner M, Falk RH: Senile systemic amyloidosis presenting with heart failure. Arch Int Med, 165: 1425-1429, 2005.
Nordlinger M, Magnani B, Skinner M, Falk RH: Is elevated plasma B-Natriuretic Peptide in amyloidosis simply a function of the presence of heart failure? Am J Cardiol 96: 982-984, 2005.
Nordlinger M, Magnani BJ, Skinner M, Falk RH: B Natiuretic Peptide (BNP) as a marker of cardiac involvement in amyloidosis. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 88-90, 2005.
Oran B, Malek K, Sanchorawala V, Wright DG, LaValley M, Quillen K, Finn KT, Skinner M, Seldin DC: Predictive factors for hematopoietic engraftment after autologous blood stem cell transplantation for AL amyloidosis. Bone Marrow Transplantation, 35: 567-575, 2005.
Prokaeva T, Ward JE, Fingar E, Kaut M, Smith P, O’Hara C, Connors LH, Skinner M, Seldin DC: Immunoglobulin (IG) light chain (LC) variable (VL) region genes demonstrate evidence for antigen selection in primary amyloidosis (AL). In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 43-45, 2005.
Reichenbach S, Guermazi A, Niu J, Neogi T, Hunter DJ, Roemer F, McLennan CE, Hernandez-Molina G, Felson DT. Prevalence of bone attrition in knee radiographs and MRI in a community-based cohort. Osteoarthritis Cartilage. Published Online First: 14 April 2008. doi:10.1016/j.joca.2008.02.001
Sanchorawala V, Wright DG, Quillen K, Kunz R, Finn KT, Malek K, Falk RH, Berk JL, Dember LM, Skinner M, Seldin DC: Treatment of AL amyloidosis with tandem cycles of high dose melphalan and autologous stem cell transplantation. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 124-126, 2005.
Sanchorawala V, Seldin DC, Magnani BJ, Skinner M, Wright DG. Serum free light chain responses after high-dose intravenous melphalan and autologous stem cell transplantation for AL (primary) amyloidosis. Bone Marrow Transplantation, 36: 597-600, 2005.
Sawyer DB, Skinner M: Cardiac amyloidosis: shifting our impressions to hopeful. Current Heart Failure Reports, 3: 64-71, 2006.
Seldin DC, Sanchorawala V, Malek K, Wright DG, Quillen K, Finn KT, Falk RH, Berk JL, Dember LM, Wiesman J, Anderson J, Skinner M: High dose melphalan and autologous stem cell transplantation (HDM/SCT) for treatment of AL amyloidosis: ten year single institutional experience. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 160-162, 2005.
Seldin DC, Skinner M: Amyloidosis, In Kelly’s Textbook of Rheumatology, 7th edition, Ed by ED Harris, S Ruddy, CB Sledge, JS Sargent, RC Budd. Elsevier, Philadelphia, pp 1697-1704, 2005.
Sengupta M, Zhang YQ, Niu JB, Guermazi A, Grigorian M, Gale D, Felson DT, Hunter DJ. High signal in knee osteophytes is not associated with knee pain. Osteoarthritis Cartilage. 2006 May;14(5):413-7.
Taskin DP, Elashoff R, Clements PJ, Goldin J, Roth MD, Furst D, Arriola E, Silver R, Strange C, Bolster M, Seibold JR, Riley DJ, Hsu VM, Varga J, Schraufnagel D, Theodore A, SIMMS R, Wise R, Wigley F, White B, Steen V, Read C, Mayes M, Parsley E, Murabak K, Connelly K, Golden J, Olman M, Fessler B, Rothfield N, Metersky M, Springmeyer S. The scleroderma lung study: oral Cyclophosphamide versus placebo for the treatment of scleroderma-related interstitial lung disease. N Eng J Med 354: 2655-2666, 2006
Theberge R, Jiang Y, Lim A, Connors LH, Ebehard J, Skinner M, Costello CE: Detection and characterization of post-translation modification in AL light chain proteins by mass spectrometry. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 46-48, 2005.
Trinkaus-Randall V, Walsh MT, Steeves S, Monis G, Connors LH, Skinner M: Cellular response of cardiac fibroblasts to amyloidogenic light chains. Am J Path, 166: 197-208, 2005.
Trinkaus-Randall V, Walsh MT, Connors LH, Steeves S, Brenner D, Liao R, Eberhard J, Skinner M: Internalization of systemic amyloid light chains and heparan sulfate proteoglycan deposition. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp142-144, 2005.
Vlad, SC, LaValley MP, McAlindon TM, Felson DT. Glucosamine for Pain in Osteoarthritis: Why do Trial Results Differ? Arthritis & Rheumatism 2007;56(7):2267-2277.
Vlad SC, Miller DR, Kowall NW, Felson DT. Protective Effects of NSAIDs on the Development of Alzheimer’s Disease. Neurology 2008;70:1672-1677
Walsh MT, Roskens V, Connors LH, Skinner M: Primary amyloidosis: conformational intermediates in immunoglobulin light chain proteins upon interaction with congo red under physiological conditions. In Amyloid and Amyloidosis, Ed by G Grateau, RA Kyle, M Skinner, CRC Press, Boca Raton, pp 40-42, 2005.
York M, Hunter DJ. Initial combination therapy with prednisone or infliximab improved outcomes in early rheumatoid arthritis more than DMARDs alone. (Commentary) ACP J Club. 2006 May-Jun;144(3):72.
York M., T. Nagai, A. Mangini, R. Lemaire, J. van Seventer and R. Lafyatis. Siglec, a macrophage marker, is increased on circulating monocytes in patients with systemic sclerosis and induced by I interferons and toll-like receptor agonists. Arthritis and Rheumatism 2007, in press.
Zhai G, A Aviv, D J Hunter, et al. Reduction of leucocyte telomere length in radiographic hand osteoarthritis: a population-based study. Ann Rheum Dis, November 1, 2006; 65(11): 1444 – 1448.
Zhang Y. Woods R. Chaisson CE. Neogi T. Niu J. McAlindon TE. Hunter D. Alcohol consumption as a trigger of recurrent gout attacks. American Journal of Medicine. 119(9):800.e13-8, 2006 Sep.
Zhang Y. Neogi T. Hunter D. Reply to letter by Choi. American Journal of Medicine. 2007 Oct.
Zhang Y, Chaisson CE, McAlindon T, Woods R, Hunter DJ, et al. The online case-crossover study is a novel approach to study triggers for recurrent disease flares. Journal of Clinical Epidemiology 60 (2007); 50-55.
Zhang Y, Terkeltaub R, Nevitt M, Xu L, Neogi T, Aliabadi P, Niu J, Felson D. Lower prevalence of chondrocalcinosis in Chinese subjects in Beijing than in White subjects in the United States. Arthritis & Rheumatism. 2006;54(11):3508-3512.
